Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines

X Xie, D Yang, Z Ye, H Tao - Chemotherapy, 2009 - karger.com
Aims: Studies on cancer biology have shown that overexpression of oncogenes (with or
without functional loss of tumor suppressor genes), which is responsible for the progression …

Recombinant antisense C-myc adenovirus increase in vitro sensitivity of osteosarcoma MG-63 cells to cisplatin

XK Xie, DS Yang, ZM Ye, HM Tao - Cancer investigation, 2006 - Taylor & Francis
C-myc is an oncogene with the important role of cell proliferation controller. It has been
found to be amplified and overexpressed in osteosarcoma. Moreover, it can promote cell …

Construction of antisense c-myc recombinant adenovirus and its anti-tumor effects on osteosarcoma cell lines MG-63 and U2OS

XK Xie, DS Yang, ZM Ye, HM Tao - Ai Zheng= Aizheng= Chinese …, 2005 - europepmc.org
Methods Recombinant adenovirus Ad-As-c-myc encoding antisense c-myc was constructed
by gene reconstruction technique, defined by polymerase chain reaction (PCR), and …

[HTML][HTML] Effects of combined c-myc and Bmi-1 siRNAs on the growth and chemosensitivity of MG-63 osteosarcoma cells

X Xie, Z Ye, D Yang, H Tao - Molecular medicine …, 2013 - spandidos-publications.com
Osteosarcoma is the most common form of primary malignant bone tumor. Patients who are
insensitive to chemotherapy treatment often have a poor prognosis. According to our …

Sensitization and caffeine potentiation of cisplatin cytotoxicity resulting from introduction of wild-type p53 gene in human osteosarcoma.

H Tsuchiya, Y Mori, Y Ueda, G Okada… - Anticancer research, 2000 - europepmc.org
The present study was performed to investigate whether the introduction of a wild-type p53
gene into human osteosarcoma cells could alter the growth rate and enhance the cytocidal …

c-myc Antisense Oligonucleotides Sensitize Human Colorectal Cancer Cells to Chemotherapeutic Drugs

MSI Abaza, A Al-Saffar, S Al-Sawan, R Al-Attiyah - Tumor Biology, 2008 - karger.com
Abstract Background/Aims: Overexpression of the c-myc oncogene frequently occurs in both
colon tumors and colon carcinoma cell lines. We examined the sensitization of human …

Modification of the sensitivity to cisplatin with c-myc over-expression or down-regulation in colon cancer cells

T Funato, K Kozawa, M Kaku, T Sasaki - Anti-cancer drugs, 2001 - journals.lww.com
Human colon cancer SW480 cells express the c-myc gene. On the other hand, SW480DDP
cell lines resistant to cisplatin exhibited decreased c-myc gene expression, but their cell …

Enhanced in vivo tumour response from Combination Carboplatin and Low Dose c-myc Antisense Oligonucleotides.

T Walker, C Dass, M Burton - Anticancer research, 2002 - researchoutput.csu.edu.au
BACKGROUND: Phosphorothioate oligonucleotides ([S] ODNs) contain a modified
phosphate backbone. Antisense [S] ODNs targeted to specific oncogenes have been used …

[HTML][HTML] Downregulation of Mcl-1 synergizes the apoptotic response to combined treatment with cisplatin and a novel fiber chimeric oncolytic adenovirus

L You, Y Wang, Y Jin, W Qian - Oncology reports, 2012 - spandidos-publications.com
The aim of this study was to examine the effects of SG511, a novel fiber chimeric oncolytic
adenovirus with E1B 55-kDa deleted, combined with cisplatin on cancer cells and to identify …

Molecular therapy with recombinant antisense c‐myc adenovirus for human gastric carcinoma cells in vitro and in vivo1,2

JP Chen, C Lin, CP Xu, XY Zhang, M Fu… - Journal of …, 2001 - Wiley Online Library
Abstract Background and Aims: This study used a recombinant antisense c‐myc adenovirus
(Ad‐ASc‐myc) to evaluate how alterations of c‐myc expression in the SGC7901 human …